These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17137911)

  • 41. PRADER-WILLI SYNDROME IN BOY OF TEN WITH PREDIABETES.
    FORSSMAN H; HAGBERG B
    Acta Paediatr (Stockh); 1964 Jan; 53():70-8. PubMed ID: 14114320
    [No Abstract]   [Full Text] [Related]  

  • 42. [Prader-Willi syndrome].
    Kurosawa K
    Ryoikibetsu Shokogun Shirizu; 2003; (39):438-41. PubMed ID: 14503311
    [No Abstract]   [Full Text] [Related]  

  • 43. Cardiac tamponade due to systemic lupus erythematosus in patient with Prader-Willi syndrome after growth hormone therapy.
    Kuramochi Y; Kato T; Sudou M; Sugano H; Takagi H; Morita T
    Lupus; 2007; 16(6):447-9. PubMed ID: 17664237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Male pubertal development and the role of androgen therapy.
    Richmond EJ; Rogol AD
    Nat Clin Pract Endocrinol Metab; 2007 Apr; 3(4):338-44. PubMed ID: 17377616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between adult dark spermatogonia and secretory capacity of Leydig cells in cryptorchidism.
    Zivkovic D; Bica DT; Hadziselimovic F
    BJU Int; 2007 Nov; 100(5):1147-9; discussion 1149. PubMed ID: 17662083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loss of the Prader-Willi syndrome protein necdin causes defective migration, axonal outgrowth, and survival of embryonic sympathetic neurons.
    Tennese AA; Gee CB; Wevrick R
    Dev Dyn; 2008 Jul; 237(7):1935-43. PubMed ID: 18570257
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth hormone therapy in children with Prader-Willi syndrome.
    Franzese A; Romano A; Spagnuolo MI; Ruju F; Valerio G
    J Pediatr; 2006 Jun; 148(6):846; author reply 846-7. PubMed ID: 16769405
    [No Abstract]   [Full Text] [Related]  

  • 48. KIGS highlights: growth hormone treatment in Prader-Willi Syndrome.
    Tauber M; Cutfield W
    Horm Res; 2007; 68 Suppl 5():48-50. PubMed ID: 18174707
    [No Abstract]   [Full Text] [Related]  

  • 49. Complex rearrangements of chromosome 15 in two patients with mild/atypical Prader Willi syndrome.
    Salavoura K; Kolialexi A; Sofocleous C; Kalaitzidaki M; Pampanos A; Kitsiou S; Mavrou A
    Genet Couns; 2008; 19(2):219-24. PubMed ID: 18618997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interdisciplinary behavioral intervention for life-threatening obesity in an adolescent with Prader-Willi syndrome - a case report.
    Messersmith NV; Slifer KJ; Pulbrook-Vetter V; Bellipanni K
    J Dev Behav Pediatr; 2008 Apr; 29(2):129-34. PubMed ID: 18408535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Water intake and risk of hyponatraemia in Prader-Willi syndrome.
    Akefeldt A
    J Intellect Disabil Res; 2009 Jun; 53(6):521-8. PubMed ID: 19302470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lymphedema in Prader-Willi syndrome.
    Heitink MV; Sinnema M; van Steensel MA; Schrander-Stumpel CT; Frank J; Curfs LM
    Int J Dermatol; 2008 Nov; 47 Suppl 1():42-4. PubMed ID: 18986486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome.
    Festen DA; Wevers M; Lindgren AC; Böhm B; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):919-25. PubMed ID: 18031326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 46,XY hypergonadotropic hypogonadism and myasthenia gravis.
    Lichiardopol C; Herlea V; Ioan V; Tomulescu V; Mixich F
    Rom J Morphol Embryol; 2006; 47(3):295-9. PubMed ID: 17308692
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Breathing deficits of the Prader-Willi syndrome.
    Zanella S; Tauber M; Muscatelli F
    Respir Physiol Neurobiol; 2009 Aug; 168(1-2):119-24. PubMed ID: 19712904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic imprinting: the paradigm of Prader-Willi and Angelman syndromes.
    Gurrieri F; Accadia M
    Endocr Dev; 2009; 14():20-8. PubMed ID: 19293572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is the brain representation of hunger normal in the Prader-Willi syndrome?
    Del Parigi A; Chen K; Reiman EM
    Int J Obes (Lond); 2007 Feb; 31(2):390; author reply 390-1. PubMed ID: 16755279
    [No Abstract]   [Full Text] [Related]  

  • 58. Is scoliosis an issue for giving growth hormone to children with Prader-Willi syndrome?
    Diene G; de Gauzy JS; Tauber M
    Arch Dis Child; 2008 Dec; 93(12):1004-6. PubMed ID: 19028967
    [No Abstract]   [Full Text] [Related]  

  • 59. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
    Fillion M; Deal C; Van Vliet G
    J Pediatr; 2009 Feb; 154(2):230-3. PubMed ID: 18814886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anaesthetic considerations in the Prader-Willi syndrome.
    Mayhew JF; Taylor B
    Can Anaesth Soc J; 1983 Sep; 30(5):565-6. PubMed ID: 6138138
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.